Cite
HARVARD Citation
Bruera, G. et al. (n.d.). P-206Intensive first line FIr-C/FOx-C association of triplet chemotherapy plus cetuximab in RAS wild-type metastatic colorectal cancer patients: Preliminary phase II data and individual limiting toxicity syndromes prediction by pharmacogenomic biomarkers. Annals of oncology. p. . [Online].